Clinical trial

PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures

NCT02936258

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-11-01

PhaseNA

Study timeline

Study start (unknown)2016-11-01Date precision: month

Registry last updated2018-02-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Standard of CarePROCEDURE

MRIPROCEDURE

MRI Targeted BiopsyPROCEDURE

Sponsors & collaborators

Canadian Urology Research Consortiumlead sponsor

Ontario Institute for Cancer Researchcollaborator

Prostate Cancer Canadacollaborator

Mapped research locations

TorontoOntario, Canada2 MontrealQuebec, Canada1 VancouverBritish Columbia, Canada1 LondonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02936258 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.